Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 390 of 5804
-
Could a common antidepressant boost cancer immunotherapy?
Disease control Recruiting nowAdvanced liver and gallbladder malignancies (including liver cancer, cholangiocarcinoma and gallbladder cancer) are a type of disease that is difficult to treat, and most patients have a short survival period. In recent years, immunotherapy (such as PD-1/PD-L1 inhibitors) has bro…
Phase: PHASE2 • Sponsor: First Affiliated Hospital of Wenzhou Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New combo strategy takes on Hard-to-Treat breast cancer
Disease control Not yet recruitingThis is a phase II, multicentre, open-label, randomised controlled trial (patients are randomly assigned to one treatment arm or the other) evaluating two treatment strategies (sacituzumab govitecan and trastuzumab deruxtecan in an alternative schema or sacituzumab govitecan alon…
Phase: PHASE2 • Sponsor: UNICANCER • Aim: Disease control
Last updated Jun 26, 2026 13:20 UTC
-
New breathing technique could save Kids' brains after cardiac arrest
Disease control Recruiting nowPediatric cardiac arrest is a life-threatening problem affecting \>15,000 hospitalized children each year. Less than half of these children survive to hospital discharge, and neurologic morbidity is common among survivors. The objective of this study is to evaluate the effectiven…
Phase: NA • Sponsor: Children's Hospital of Philadelphia • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New hope for advanced endometrial cancer: drug combo trial launches
Disease control Recruiting nowThe researchers are doing this study to find out whether elacestrant is an effective and safe treatment alone or in combination with abemaciclib for people with advanced or recurrent ER+ endometrial cancer.
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
New hope for advanced cervical cancer: Triple-Drug combo trial launches
Disease control Not yet recruitingThis is a multicenter, randomized, open-label Phase II/III clinical study, aiming to evaluate the efficacy and safety of LB1410 in combination with lenvatinib (whether in combination with LB4330)versus the chemotherapy regimen selected by the investigators for patients with advan…
Phase: PHASE2, PHASE3 • Sponsor: L & L Bio Co., Ltd., Ningbo, China • Aim: Disease control
Last updated Jun 26, 2026 17:31 UTC
-
Gene-Tailored drugs aim to tackle tough bile duct cancer
Disease control Not yet recruitingThis is a multi-center, real-world study aiming to evaluate the efficacy and safety of precision treatment for advanced cholangiocarcinoma (CCA) with different molecular subtypes.
Sponsor: Mao-Lin Yan • Aim: Disease control
Last updated Jun 26, 2026 15:27 UTC
-
Brain zaps and VR worlds: a new hope for early Alzheimer's?
Disease control Not yet recruitingAs populations age, Alzheimer's disease (AD) is increasing while disease-modifying drugs remain elusive, making early diagnosis and intervention essential. Building on advances in neuromodulation and virtual reality (VR), we target amnestic mild cognitive impairment (aMCI)-the pr…
Phase: NA • Sponsor: Yuan Shen • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
New stroke surgery could spare patients a second operation
Disease control Not yet recruitingThis clinical study investigates Expansion-floating Craniotomy (EC), a novel surgical technique for treating life-threatening malignant cerebral edema following large hemispheric infarction (commonly known as massive stroke). Malignant edema causes rapid increases in intracranial…
Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
New study aims to curb veteran suicides after community mental health stays
Symptom relief Recruiting nowThe study is of high importance to Veterans' health because it will study a suicide prevention intervention in a Veteran population that is at high risk of suicide but has not been a specific focus of the Veteran Affairs' (VA's) suicide prevention efforts. Specifically, a growing…
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
New hope for recurrent cervical cancer: drug cocktail targets HER2
Disease control Not yet recruitingThis is a single-arm study. The efficacy and safety of Disitamab Vedotin combined with Apalutamide and Toripalimab in the second-line treatment of HER2-expressing recurrent cervical cancer are evaluated based on the following indicators: Primary evaluation indicator: Objective R…
Phase: PHASE2 • Sponsor: Qilu Hospital of Shandong University • Aim: Disease control
Last updated Jun 26, 2026 17:04 UTC
-
New hope for kids with tough blood cancers: drug cocktail trial launches
Disease control Recruiting nowHEM-iSMART is a master protocol which investigates multiple investigational medicinal products in children, adolescents and young adults (AYA) with relapsed/refractory (R/R) ALL and LBL. Sub-protocol C is a phase I/II trial evaluating the safety and efficacy of ruxolitinib and ve…
Phase: PHASE1, PHASE2 • Sponsor: Princess Maxima Center for Pediatric Oncology • Aim: Disease control
Last updated Jun 26, 2026 17:34 UTC
-
New combo therapy targets stomach cancer lymph nodes
Disease control Recruiting nowThis is a randomized, controlled, multicenter phase II clinical trial evaluating the efficacy and safety of conversion therapy combined with radical gastrectomy and adjuvant radiotherapy targeting para-aortic (station 16) lymph nodes in patients with gastric adenocarcinoma and is…
Phase: PHASE2 • Sponsor: Jinbo Yue • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Radiation before surgery: a new hope for tough breast cancers?
Disease control Not yet recruitingApproximately 20% of breast cancer patients in our country are in the locally advanced stage. The relatively low overall survival rate, high recurrence rate and distant metastasis risk of these patients significantly affect the therapeutic efficacy and survival. Preoperative radi…
Phase: NA • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 26, 2026 16:14 UTC
-
New Clot-Busting device could save stroke patients
Disease control Recruiting nowThe goal of this study is to evaluate the safety and performance of the CONDA stent retriever in patients with acute ischemic stroke due to large vessel occlusion, treated within 24 hours of symptom onset. The main objectives are: * To determine the rate of device success, defi…
Phase: NA • Sponsor: Anaconda Biomed S.L. • Aim: Disease control
Last updated Jun 26, 2026 18:26 UTC
-
Could a common steroid boost stroke recovery?
Disease control Not yet recruitingIt is uncertain whether intravenous methylprednisolone improves outcomes for acute anterior circulation large vessel occlusion (LVO) patients with a large infarct core. In this study, the investigators hypothesize that methylprednisolone plus endovascular thrombectomy (EVT) might…
Phase: NA • Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Disease control
Last updated Jun 26, 2026 18:28 UTC
-
Coffee for preemies? study tests caffeine to shield tiny kidneys
Prevention CompletedRecent observational data point towards a reduced incidence of acute kidney injury (AKI) with early caffeine use, but high-quality randomized controlled trials comparing early caffeine initiation to supportive therapy alone are lacking. This study aims to fill this critical gap b…
Phase: NA • Sponsor: Muhammad Aamir Latif • Aim: Prevention
Last updated Jun 27, 2026 12:37 UTC
-
Tiny radiation seeds take aim at deadly brain tumors
Disease control Recruiting nowA unique approach for cancer treatment employing intratumoral diffusing alpha radiation emitter device for the treatment of recurrent Glioblastoma
Phase: NA • Sponsor: Alpha Tau Medical LTD. • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
3D-Printed tumors could revolutionize liver cancer drug matching
Knowledge-focused OngoingPrimary liver cancer, predominantly hepatocellular carcinoma (HCC), represents a major global health burden, with high incidence and mortality rates. It ranks among the leading causes of cancer-related deaths worldwide, due largely to late diagnosis and limited therapeutic effica…
Sponsor: Peking Union Medical College Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC
-
New hope for tough lymphoma: stem cell transplant trial for Non-Responders
Disease control Recruiting nowThis study is a multicenter, two-arm, prospective clinical trial, comprising two groups: the allogeneic hematopoietic stem cell transplantation group (Allo-HSCT) and the alternative salvage regimens. It aims to evaluate the efficacy and safety of Allo-HSCT and alternative salvage…
Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New surgery aims to stop arm swelling after breast cancer treatment
Prevention Recruiting nowThe goal of this clinical trial is to evaluate the effectiveness of Immediate Lymphatic Reconstruction (ILR) in preventing breast cancer-related lymphedema (BCRL) in high-risk patients. It will also assess the safety and quality of life outcomes associated with the procedure. The…
Phase: NA • Sponsor: University of South Florida • Aim: Prevention
Last updated Jun 27, 2026 12:26 UTC